While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past ...

A favorable appeals court ruling repositioned a coalition of universities and Nobel laureates to win credit for inventing a ...

CRISPR Therapeutics is still losing money, but it also finished March with $1.9 billion in cash after burning through $134 ...

Researchers say the CRISPR-based technique used could eventually be employed to treat more people with rare genetic diseases ...

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could ...

Princeton University awarded honorary degrees to Omar M. Yaghi, Daniel Chee Tsui, Nancy Weiss Malkiel, Joshua ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

In a major breakthrough, a patient has been treated with a personalized CRISPR therapeutic that aims to cure their rare genetic disease... | Genetics And Genomics ...